{
    "organizations": [],
    "uuid": "b98f85adf17ade170c92c57b2e68c3fe0cbecade",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mynd-analytics-awarded-canadian-pa/brief-mynd-analytics-awarded-canadian-patent-on-neuromodulation-platformpredicts-patients-likely-to-respond-to-tms-for-treating-depression-idUSFWN1PY11D",
    "ord_in_thread": 0,
    "title": "BRIEF-MYnd Analytics Awarded Canadian Patent On Neuromodulation Platform Predicts Patients Likely To Respond To TMS For Treating Depression",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - MYnd Analytics Inc:\n* MYND ANALYTICS AWARDED CANADIAN PATENT ON NEUROMODULATION PLATFORM; PREDICTS PATIENTS LIKELY TO RESPOND TO TMS FOR TREATING DEPRESSION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T20:39:00.000+02:00",
    "crawled": "2018-02-09T16:25:54.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "mynd",
        "analytics",
        "inc",
        "mynd",
        "analytics",
        "awarded",
        "canadian",
        "patent",
        "neuromodulation",
        "platform",
        "predicts",
        "patient",
        "likely",
        "respond",
        "tm",
        "treating",
        "depression",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}